Mahamaya Steel Industries Limited
Monthly Business Updates
Mahamaya Steel Industries Limited has informed the Exchange regarding Monthly Business Updates for the month of July 2026, announcing sales figures of 15589.190 MT.
BSE & NSE corporate filings with AI summaries
Mahamaya Steel Industries Limited
Mahamaya Steel Industries Limited has informed the Exchange regarding Monthly Business Updates for the month of July 2026, announcing sales figures of 15589.190 MT.
Morepen Laboratories Limited
Morepen Laboratories Limited has informed the Exchange that Record date for the purpose of Final Dividend is 19-Sep-2026. The company has also approved the financial results for the quarter ended 30th June 2026, and has announced the re-appointment of Mr. Sushil Suri as the Chairman & Managing Director of the company.
GPT Healthcare Limited
GPT Healthcare Limited informed the Exchange about the link of recording of a conference call held on August 4, 2026, to discuss the un-audited financial results for the 1st quarter ended on June 30, 2026.
Butterfly Gandhimathi Appliances Limited
Butterfly Gandhimathi Appliances Limited held its 39th Annual General Meeting through video conferencing on August 4, 2026, in compliance with relevant circulars and applicable provisions. The meeting considered the adoption of audited financial statements, appointment of a director, and ratification of remuneration payable to cost auditors.
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited has submitted its financial results for the quarter ended June 30, 2026, with the Board of Directors approving the consolidated and standalone unaudited financial results along with the Limited Review Report issued by the Statutory Auditors.
Wonderla Holidays Limited
Wonderla Holidays Limited has submitted its financial results for the quarter ended June 30, 2026, with a profit before tax of Rs. 9,346.54 lakhs and a total revenue of Rs. 25,210.21 lakhs. The company has also allotted 15,105 shares to employees and granted 8,980 stock options to two employees.
Repro India Limited
Repro India Limited has informed the Exchange about Investor Presentation, showcasing Q1 FY27 performance highlights, including 20% YoY revenue growth, stable gross margins, and exceptional gain from Mahape land sale.
Emami Limited
Emami Limited reported a 15% topline growth in Q1FY27, with consolidated revenues reaching ₹1,039 crore. Domestic Business grew 20%, while International Business declined 12% due to West Asia disruptions. EBITDA grew 6% to ₹226 crore despite higher input costs.
Summit Securities Limited
Summit Securities Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Emami Limited
Emami Limited has reported a 15% topline growth in Q1FY27, with domestic business growing 20% and international business declining 12% due to West Asia disruptions. The company has also made strategic investments to strengthen its future growth portfolio.
Morepen Laboratories Limited
Morepen Laboratories Limited has announced its financial results for Q1 FY27, reporting its highest-ever quarterly revenue and earnings, supported by better operating leverage, improved performance on API front, strong export growth and full scale commercialization of CDMO mandate.
Bata India Limited
Bata India Limited has informed about the schedule of its Post Earnings Call (Group Call) for Q1FY27, to be held on August 13, 2026, at 4:30 pm IST.
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 173.07 crore and revenue from operations of Rs. 2,149.71 crore.
Raymond Realty Limited
Raymond Realty Limited has informed the Exchange about a conference call to discuss its financial performance for the First Quarter ended June 30, 2026.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about the schedule of a Q1FY27 Earnings Conference Call to be held on Friday, 07th August, 2026 at 12:00 p.m. IST. The call will be hosted by Go India Advisors and will feature company participants Mr. Zulfiquar Kamal, Mr. Shyam Mohan Patro, and Mr. Zain Daud.
Capillary Technologies India Limited
Capillary Technologies India Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and received a Limited Review Report from its independent auditor, Walker Chandiok & Co LLP.
Indian Metals & Ferro Alloys Limited
Indian Metals & Ferro Alloys Ltd (IMFA) reported record revenue and robust financial performance in Q1 FY27, driven by higher ferro chrome output and firm prices. The company's Greenfield Expansion Project at Kalinganagar is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. IMFA has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, expected to be available by June 2027.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, total income growing by 23.9% YoY to ₹620 Crores, IND-AS EBITDA growing by 25.2% YoY to ₹177 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.
Indian Metals & Ferro Alloys Limited
Indian Metals & Ferro Alloys Ltd (IMFA) has announced its Q1 FY2027 earnings, reporting a record revenue of ₹960.45 crore, up 50% from ₹641.54 crore in Q1 FY26, driven by higher ferro chrome output and firm prices. The company's EBITDA and PAT also saw significant increases, to ₹281.27 crore and ₹191.49 crore, respectively. IMFA's Greenfield Expansion Project at Kalinganagar (KNR 1) is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. The company has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, which will contribute to its green footprint.
Capillary Technologies India Limited
Capillary Technologies India Limited has announced its financial results for the first quarter ended June 30, 2026, with a 43% year-on-year growth in operating revenue and a 132% year-on-year growth in adjusted EBITDA. The company reported strong profitability metrics with normalized profit after tax (PAT) growing exponentially (+3,320%) driven by operational efficiencies and integration synergies across the acquired businesses.